These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8174822)

  • 1. Donor selection policies: do they work and what more?
    Cash JD
    Dev Biol Stand; 1993; 81():65-70. PubMed ID: 8174822
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-remunerated donations.
    Leikola J
    Dev Biol Stand; 1993; 81():51-6. PubMed ID: 8174820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collection of source material from remunerated donors.
    Rodell MB
    Dev Biol Stand; 1993; 81():57-64. PubMed ID: 8174821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor screening: an overview of current regulation and practices in Europe.
    Tjabbes H
    Transplant Proc; 1996 Oct; 28(5):2950-2. PubMed ID: 8908136
    [No Abstract]   [Full Text] [Related]  

  • 5. Perceived deterrents to being a plasmapheresis donor in a voluntary, nonremunerated environment.
    Bagot KL; Bove LL; Masser BM; Bednall TC; Buzza M
    Transfusion; 2013 May; 53(5):1108-19. PubMed ID: 22998759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the envelope: can we increase the organ donor pool through the appropriate application of infectious disease principles?
    Rubin RH
    Transpl Infect Dis; 2002 Sep; 4(3):115-6. PubMed ID: 12421454
    [No Abstract]   [Full Text] [Related]  

  • 7. Donor blood procurement and utilisation at the University of Benin Teaching Hospital, Benin City.
    Enosolease ME; Imarengiaye CO; Awodu OA
    Afr J Reprod Health; 2004 Aug; 8(2):59-63. PubMed ID: 15623119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical approaches to limited resources.
    Lin CK
    Vox Sang; 2004 Jul; 87 Suppl 2():172-5. PubMed ID: 15209910
    [No Abstract]   [Full Text] [Related]  

  • 9. Donor safety in plasmapheresis.
    Lundsgaard-Hansen P
    Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determinants of the willingness to donate an organ among young adults: evidence from the United States and the European Union.
    Mocan N; Tekin E
    Soc Sci Med; 2007 Dec; 65(12):2527-38. PubMed ID: 17765372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policies regarding the transplantation of hepatitis C-positive candidates and donor organs.
    Lake KD; Smith CI; LaForest SK; Allen J; Pritzker MR; Emery RW
    J Heart Lung Transplant; 1997 Sep; 16(9):917-21. PubMed ID: 9322141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rethinking the donation experience: an integrated approach to improve the efficiency and the quality of each blood donation experience.
    Daigneault S; Blais J
    Vox Sang; 2004 Jul; 87 Suppl 2():72-5. PubMed ID: 15209883
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of normal children as participants in research on therapy.
    Gordon B; Prentice E; Reitemeier P
    IRB; 1996; 18(3):5-8. PubMed ID: 11654409
    [No Abstract]   [Full Text] [Related]  

  • 14. Donor deal. Before you can get an organ, perhaps you should be willing to give one.
    Kingsbury K
    Time; 2007 Jun; 169(26):53-4. PubMed ID: 17899638
    [No Abstract]   [Full Text] [Related]  

  • 15. Donation after cardiac death and the science of organ donation.
    O'Connor K; Delmonico FL
    Clin Transpl; 2005; ():229-34. PubMed ID: 17424742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The experience of a blood-bank doctor in Chile].
    Martinez C
    Transfus Clin Biol; 2006 Sep; 13(3):203-5. PubMed ID: 17010653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some moral connections between organ procurement and organ distribution.
    Childress JF
    J Contemp Health Law Policy; 1987; 3():85-110. PubMed ID: 10282314
    [No Abstract]   [Full Text] [Related]  

  • 18. Donor funding priorities for communicable disease control in the developing world.
    Shiffman J
    Health Policy Plan; 2006 Nov; 21(6):411-20. PubMed ID: 16984894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Nov; 46(226):57480-1. PubMed ID: 10253366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended criteria donors: the case for liver procurement in donors with a central nervous system malignancy.
    Detry O
    Liver Transpl; 2009 Jun; 15(6):670-1. PubMed ID: 19479814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.